Working… Menu
Trial record 1 of 1 for:    tevogen
Previous Study | Return to List | Next Study

Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04765449
Recruitment Status : Recruiting
First Posted : February 21, 2021
Last Update Posted : September 23, 2021
Tevogen Bio Inc
Information provided by (Responsible Party):
Thomas Jefferson University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 29, 2022
Estimated Study Completion Date : July 29, 2022